Global Grad Show unveils 150 game-changing ideas to change the world
3,681 graduates in 464 universities across 70 countries submitted entries making the 7th edition of Global Grad Show the largest to date An Alexa with a heart; Next-generation disease decoding software; Self-healing construction materials and textiles; Robots that regenerate land and sea ecosystems; Steering wheels to monitor health; A wearable device for...
I-Mab and Roche Diagnostics Announce Strategic Collaboration to Co-Develop Companion Diagnostics Solutions for I-Mab’s Innovative Pipeline at the 4th CIIE
SHANGHAI and GAITHERSBURG, Md., Nov. 8, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the Company has entered into a strategic collaboration with Roche Diagnostics, a global leader in in vitro diagnostics industry, to co-develop...
Farmmi Announces Latest Multi-Product Sales Win
LISHUI, China, Nov. 8, 2021 /PRNewswire/ -- Farmmi, Inc. ("Farmmi" or the "Company") (NASDAQ: FAMI), an agriculture products supplier in China, today announced the Company's subsidiary Zhejiang Farmmi Biotechnology Co., Ltd., won a new multi-product order for its popular dried black fungus and whole dried mushrooms. The customer will export Farmmi's...
BARDA and Clarivate Partner to Identify Therapeutics Which Can Be Repurposed as Medical Countermeasures to Chemical Exposure
LONDON, Nov. 8, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced a new partnership with the Biomedical Advanced Research and Development Authority (BARDA), which provides an integrated, systematic approach to the development of the necessary vaccines, drugs,...
RedHill Biopharma and South Korea’s Kukbo Co. Announce a Strategic Investment of Up To $10 Million in RedHill
TEL AVIV, Israel and RALEIGH, NC, Nov. 8, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered into a strategic agreement with Kukbo Co. Ltd. (Kospi: 001140) ("Kukbo"), a South Korean corporation, for the sale of RedHill's American Depositary...
RadLink, Singapore’s Leading Imaging Center, Adapts Lunit AI to Analyze Chest X-rays and Mammograms
SEOUL, South Korea, Nov. 8, 2021 /PRNewswire/ -- Lunit today announced a Reference Site Agreement with RadLink, a subsidiary of the Fullerton Health Group, Singapore's leading private diagnostic and molecular imaging service provider. As a leading medical AI company, Lunit provides AI software that detects and analyzes radiology images. The most mature...
MYEASYDOSE IS COMMITTED TO PROVIDING PATIENTS WITH ONLINE HEALTH COACHING
MyEasyDose is one of 16 sunshinedrugs.com pharmacies operating across Ontario and is committed to helping patients get better with online health coaching.
MyEasyDose offers a true virtual pharmacy experience and has quickly become a leader in online prescription fulfillment and pill packaging solutions. They currently service residents in Ontario, Canada at this time, but...
Cigna Study Shows Hongkongers Ranked the Sixth Most Stressed Population Globally
HONG KONG, Nov. 8, 2021 /PRNewswire/ -- Cigna Hong Kong released today the Hong Kong findings of the latest Cigna 360 Well-Being Survey. This research is the seventh in a series of studies, which aims to better understand the impact of the COVID-19 pandemic on people's well-being, and includes new areas such as virtual health, whole health, resilience and remote...
Ascletis and Suzhou Alphamab Expand their Partnership into Worldwide License Agreement for ASC22 (Envafolimab) to Treat Hepatitis B and Other Viral Diseases
HANGZHOU, China and SHAOXING, China and SUZHOU, China, Nov. 8, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK) and Suzhou Alphamab Co., Ltd. (Suzhou Alphamab) jointly announce today that Ascletis' subsidiary and Suzhou Alphamab have entered into an exclusive and worldwide license agreement outside Greater China for ASC22 (Envafolimab) to treat all viral diseases including Hepatitis B. ASC22, also known...
Everest Medicines Announces Up to HK$100 million Additional Share Repurchase Program
SHANGHAI, Nov. 8, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest" or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Asia, today announced that its board directors resolved to increase the share repurchase program by up to HK$100 million. The Company has repurchased 1,615,500 ordinary...
